KAICO

About:

KAICO is a biotechnology company that provides hard-expressing proteins to develop drugs with a silkworm-baculovirus expression system.

Website: https://www.kaicoltd.jp

Twitter/X: KAICO92678804

Top Investors: Mizuho Capital, FFG Venture Business Partners, ITOCHU Technology Ventures, Tokyo Century, Long Black Partners

Description:

KAICO is a pharmaceuticals, diagnostic drugs production company.

Total Funding Amount:

590M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Nishiku, Fukuoka, Japan

Founded Date:

2018-04-02

Contact Email:

info-kaico(AT)kaicoltd.jp

Founders:

Kenta Yamato

Number of Employees:

11-50

Last Funding Date:

2024-01-19

IPO Status:

Private

Industries: